Global logistics strategies for cell and gene therapies – BioPharma Dive
BioPharma Dive |
Global logistics strategies for cell and gene therapies
BioPharma Dive In the past two decades, gene-based clinical trials have increased by almost 500%. The global market for regenerative medicines – including cell therapies, gene/gene-modified cell therapy and tissue engineering – is poised to reach $67 billion in 2020. |
